Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice. [electronic resource]
Producer: 20170829Description: 400-10 p. digitalISSN:- 1365-2036
- 2-Naphthylamine
- Adult
- Black or African American
- Aged
- Aged, 80 and over
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Benzimidazoles -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes
- Drug Combinations
- Drug Therapy, Combination
- Female
- Fluorenes -- therapeutic use
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- blood
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- RNA, Viral -- blood
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Uracil -- analogs & derivatives
- Valine
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.